Connect With Us
Subscribe Now
Log In
Home
News
Education
Health
Tech
STEM
Advanced Manufacturing & Logistics
Life Sciences
Ag INnovation
INPower
Videos
Big Wigs
Submit Big Wigs
Events
Innovate Southwest Indiana â Evansville
Innovate West Central Indiana – Terre Haute
Innovate East Central – Muncie
Innovate Northeast Indiana – Fort Wayne
Newsletters
Podcasts
On-Air
TV & Radio Listings
Content Studio
Sponsored Content
Contact
About IIB
Meet the Team
Contact Us
Advertise
Gift Cards
Flagship Stations
Gerry’s Message
Speaking Engagement Request
Search
GO
Connect With Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Longeveron Inc. - Class A Common stock
(NQ:
LGVN
)
0.5216
-0.0030 (-0.57%)
Streaming Delayed Price
Updated: 12:07 PM EST, Mar 5, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Longeveron Inc. - Class A Common stock
< Previous
1
2
3
4
5
6
7
8
9
...
12
13
Next >
LGVN Shares Rise After Investigational Therapy Shows Improvement In Age-Related Frailty In Study
↗
February 25, 2026
Longeveron said that intravenous laromestrocel improved the physical condition of patients with age-related clinical frailty after nine months, compared to placebo.
Via
Stocktwits
12 Health Care Stocks Moving In Tuesday's After-Market Session
↗
November 04, 2025
Via
Benzinga
Earnings Scheduled For November 4, 2025
↗
November 04, 2025
Via
Benzinga
Earnings Preview For Longeveron
↗
November 03, 2025
Via
Benzinga
These stocks have an unusual volume in today's session
↗
August 14, 2025
Join us as we delve into today's session and uncover the stocks that are standing out with unusual volume.
Via
Chartmill
Preview: Longeveron's Earnings
↗
August 12, 2025
Via
Benzinga
Earnings Scheduled For May 8, 2025
↗
May 08, 2025
Via
Benzinga
Earnings Scheduled For November 12, 2024
↗
November 12, 2024
Via
Benzinga
A Look Ahead: Longeveron's Earnings Forecast
↗
November 11, 2024
Via
Benzinga
Peeling Back The Layers: Exploring Longeveron Through Analyst Insights
↗
November 04, 2024
Via
Benzinga
Longeveron Posts 32% Revenue Drop in Q2
↗
August 13, 2025
Via
The Motley Fool
Longeveron Inc. (NASDAQ:LGVN) Q2 2025 Earnings: Revenue Misses, EPS Narrower Than Expected
↗
August 13, 2025
Longeveron Inc. (LGVN) reported Q2 2025 earnings with revenue missing estimates at $320K but a narrower EPS loss of $0.33. Stock fell 3.5% post-earnings amid clinical progress in HLHS and Alzheimer's...
Via
Chartmill
Top stock movements in today's session.
↗
August 08, 2025
Curious to know what's happening on the US markets one hour before the close of the markets on Friday? Join us as we explore the top gainers and losers in today's session.
Via
Chartmill
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
↗
August 05, 2025
Via
Benzinga
Beyond The Numbers: 4 Analysts Discuss Longeveron Stock
↗
August 27, 2024
Via
Benzinga
Longeveron (LGVN) Stock Pops on Phase 2 Trial Updates
↗
July 29, 2024
The good news on Lomecel-B comes at an opportune time for Longeveron and LGVN stock -- it could attract a buyer.
Via
InvestorPlace
Earnings Scheduled For August 13, 2025
↗
August 13, 2025
Via
Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
↗
August 04, 2025
Via
Benzinga
Which stocks are moving after the closing bell on Monday?
↗
August 04, 2025
After the conclusion of the US market's regular session on Monday, let's examine the after-hours session and unveil the notable performers among the top gainers and losers.
Via
Chartmill
Stay updated with the stocks that are on the move in today's after-hours session.
↗
February 28, 2025
After the closing bell on Friday, let's take a glimpse of the US markets and explore the top gainers and losers in today's after-hours session.
Via
Chartmill
Earnings Scheduled For February 28, 2025
↗
February 28, 2025
Via
Benzinga
Why LENZ Therapeutics Shares Are Trading Higher By Around 18%; Here Are 20 Stocks Moving Premarket
↗
October 28, 2024
Via
Benzinga
LGVN Stock Earnings: Longeveron Misses EPS, Beats Revenue for Q2 2024
↗
August 14, 2024
LGVN stock results show that Longeveron missed analyst estimates for earnings per share but beat on revenue for the second quarter of 2024.
Via
InvestorPlace
EXCLUSIVE: Top 20 Most-Searched Tickers On Benzinga Pro In July 2024 – Where Do Tesla, Nvidia, Apple, CrowdStrike Rank?
↗
August 01, 2024
A look at the most-searched tickers on Benzinga Pro for the month of July shows some familiar names like Tesla, Nvidia and Apple. Here's a look at the others.
Via
Benzinga
The Top 3 Small-Cap Stocks to Buy Now: Summer 2024
↗
August 01, 2024
Small-cap stocks are on the rise once again as the Federal Reserve ponders cutting interest rates, which has held back the sector.
Via
InvestorPlace
Topics
Economy
Why Bank of Marin Bancorp Shares Are Trading Lower? Here Are Other Stocks Moving In Monday's Mid-Day Session
↗
July 29, 2024
Via
Benzinga
Why Is Cognition Therapeutics (CGTX) Stock Down 33% Today?
↗
July 29, 2024
Cognition Therapeutics stock is down on Monday after CGTX investors read the latest data from a Phase 2 clinical trial report.
Via
InvestorPlace
Why Is Alzheimer's-Focused Longeveron Stock Trading Higher On Monday?
↗
July 29, 2024
Longeveron presented promising Phase 2a clinical trial data for Lomecel-B at the AAIC 2024. The trial showed the drug's safety and efficacy in treating Alzheimer's, demonstrating slowed disease...
Via
Benzinga
Northrop Grumman To Rally Around 20%? Here Are 10 Top Analyst Forecasts For Monday
↗
July 29, 2024
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
↗
July 29, 2024
Pre-market stock movers are worth diving into as we check out all of the hottest news affecting shares on Monday morning!
Via
InvestorPlace
< Previous
1
2
3
4
5
6
7
8
9
...
12
13
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
